Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-22-045711
Filing Date
2022-12-15
Accepted
2022-12-15 17:00:30
Documents
2
Group Members
COREY GOODMANROBERT ADELMANVENBIO GLOBAL STRATEGIC GP III, L.P.VENBIO GLOBAL STRATEGIC GP III, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A brhc10045470_sc13da.htm SC 13D/A 174530
2 EXHIBIT 99.5 brhc10045470_ex99-5.htm EX-99.5 12000
  Complete submission text file 0001140361-22-045711.txt   188216
Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic Fund III, L.P. (Filed by) CIK: 0001739920 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Subject) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92974 | Film No.: 221465526
SIC: 2834 Pharmaceutical Preparations